Tamura et al., 1993 - Google Patents
Risk of liver cirrhosis and hepatocellular carcinoma in subjects with hepatitis B and delta virus infection: a study from Kure, JapanTamura et al., 1993
View PDF- Document ID
- 775708750852006189
- Author
- Tamura I
- Kurimura O
- Koda T
- Ichimura H
- Katayama S
- Kurimura T
- Inaba Y
- Publication year
- Publication venue
- Journal of gastroenterology and hepatology
External Links
Snippet
To investigate the effect of hepatitis delta virus (HDV) superinfection on the long‐term outcome of Japanese subjects with chronic hepatitis B virus (HBV) infection, we examined the presence of antibodies to hepatitis delta antigen (anti‐HD) in serial serum samples …
- 206010073071 Hepatocellular carcinoma 0 title abstract description 47
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay for hepatitis non-A, non-B hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
- G01N33/5761—Hepatitis B
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tamura et al. | Risk of liver cirrhosis and hepatocellular carcinoma in subjects with hepatitis B and delta virus infection: a study from Kure, Japan | |
Lee et al. | Seroepidemiology of hepatitis C virus infection in Taiwan | |
Darwish et al. | High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: a pilot study | |
Dienstag | Sexual and perinatal transmission of hepatitis C | |
DE COCK et al. | Epidemic non-A, non-B hepatitis in patients from Pakistan | |
Guadagnino et al. | Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy | |
Chu et al. | Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus | |
Kao et al. | Transmission of hepatitis C virus between spouses: the important role of exposure duration | |
Nakatsuji et al. | Detection of Chronic Hepatitis C Virus Infection by Four Diagnostic Systems: First–Generation and Second–Generation Enzyme–Linked Immunosorbent Assay, Second–Generation Recombinant Immunoblot Assay and Nested Polymerase Chain Reaction Analysis | |
Kiyosawa et al. | The significance of blood transfusion in non-A, non-B chronic liver disease in Japan | |
Yousuf et al. | Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up | |
Lefrère et al. | Prevalence of GB virus type C/hepatitis G virus RNA and of anti‐E2 in individuals at high or low risk for blood‐borne or sexually transmitted viruses: evidence of sexual and parenteral transmission | |
Yamakawa et al. | Higher elimination rate of hepatitis C virus among women | |
Nishioka et al. | Antibody to the hepatitis C virus in acute hepatitis and chronic liver diseases in Japan | |
Sheu et al. | Prevalence of anti‐HCV and HCV viremia in hemodialysis patients in Taiwan | |
Bortolotti et al. | Cryptogenic chronic liver disease and hepatitis C virus infection in children | |
SHIOMI et al. | Effect of drinking on the outcome of cirrhosis in patients with hepatitis B or C | |
Wu et al. | Sexual transmission of hepatitis D virus infection in Taiwan | |
Arguillas et al. | Seroepidemiology of hepatitis C virus infection in the Philippines: a preliminary study and comparison with hepatitis B virus infection among blood donors, medical personnel, and patient groups in Davao, Philippines | |
Gunaid et al. | Acute sporadic hepatitis in the Republic of Yemen | |
Maggiore et al. | A Retrospective Study of the Role of Delta Agent Infection in Children With Hbsag–Positive Chronic Hepatitis | |
Acharya | Hepatitis D virus (HDV) infection in severe forms Introduction of liver diseases in north India | |
Takahashi et al. | Intrafainilial transmission of hepatitis C | |
Hsu et al. | Hepatitis D virus infection in children with acute or chronic hepatitis B virus infection in Taiwan | |
Lai et al. | Non-A, non-B, non-C hepatitis: its significance in pediatric patients and the role of GB virus-C |